Improving Fecal Occult Blood Test Completion Rates Among Veterans
| Status: | Completed |
|---|---|
| Conditions: | Colorectal Cancer, Colorectal Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | February 2012 |
| End Date: | June 2015 |
This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial
incentives directly integrated into primary care can improve fecal occult blood test (FOBT)
completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs
Medical Center (PVAMC) in 2 stages. In stage 1, we hypothesize that, compared to usual care,
$5, $10, $20 incentives will each lead to a statistically significant increase in the rate
of FOBT completion. We also hypothesize that there will be a direct dose-response
relationship between the incentive amount and rates of FOBT completion. In stage 2, we
hypothesize that a lottery-based incentive and a raffle-based incentive will both lead to a
statistically significant increase in the rate of FOBT completion compared to a fixed
payment incentive with an equivalent dollar per patient value.
incentives directly integrated into primary care can improve fecal occult blood test (FOBT)
completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs
Medical Center (PVAMC) in 2 stages. In stage 1, we hypothesize that, compared to usual care,
$5, $10, $20 incentives will each lead to a statistically significant increase in the rate
of FOBT completion. We also hypothesize that there will be a direct dose-response
relationship between the incentive amount and rates of FOBT completion. In stage 2, we
hypothesize that a lottery-based incentive and a raffle-based incentive will both lead to a
statistically significant increase in the rate of FOBT completion compared to a fixed
payment incentive with an equivalent dollar per patient value.
Inclusion Criteria:
- PVAMC outpatients who are prescribed an FOBT kit in Module B or C during the study
period.
Exclusion Criteria:
- None. All PVAMC outpatients who are prescribed an FOBT kit in Module B or C during
the study period will be eligible.
We found this trial at
1
site
Click here to add this to my saved trials
